🦠💊 More than 250 people have joined a trial testing #obeldesivir as post-exposure protection against #Ebola during Congo’s deadly #Bundibugyo #virus #outbreak, which currently has no approved #vaccine or treatment.
@microbesinfo.bsky.socialExplore
@microbesinfo.bsky.social